Sort
85,873 grants matching “alzheimers”
Transcriptional control of proteostasis and aging
$1,925,000Andrew Vaughn Samuelson · University Of Rochester · RF1 · FY2019 · AG
Regulation of Neurotransmitter Action by Steroid Hormones in Females
$1,925,000Istvan Mody · University Of California Los Angeles · RF1 · FY2016 · AG
Cell and molecular pathobiology of Alzheimer's Disease
$1,924,962Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2007 · AG
Synergistic patterned neurodegeneration by APP and APOE4
$1,924,895Jonathan T Pierce-Shimomura · University Of Texas At Austin · RF1 · FY2017 · AG
Social Assistive Robot Interface for People with Alzheimer's and Other Dementias to Aid in Care Management
$1,924,651Daniel S Hedin · Advanced Medical Electronics Corporation · R44 · FY2021 · AG
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
$1,924,622Sudha Seshadri · University Of Texas Hlth Science Center · R01 · FY2022 · AG
TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells
$1,923,939Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2017 · HG
Generating Evidence on Deprescribing Safety
$1,923,910Elizabeth A Bayliss · Kaiser Foundation Research Institute · RF1 · FY2021 · AG
Modeling Neuronal Aging and Alzheimer's Disease in Human Neurons Directly Converted from Fibroblasts
$1,923,720Andrew Yoo · Washington University · RF1 · FY2017 · AG
Metabolic mechanisms of cognitive decline in aging and AD mediated by inflammatory PGE2 signaling
$1,923,592Katrin I Andreasson · Stanford University · RF1 · FY2023 · AG
Multi-omic Brain Cell Atlas of Alzheimer's Disease Progression
$1,923,515Bing Ren · University Of California, San Diego · R56 · FY2020 · AG
The role of TREM2 in human microglial function and Alzheimer disease pathogenesis
$1,921,750Mathew Mark Blurton-Jones · University Of California-Irvine · RF1 · FY2014 · AG
Neural circuit mechanisms underlying AD-related memory impairments
$1,921,280Xiangmin Xu · University Of California-Irvine · RF1 · FY2020 · AG
ADCC Genomic Medicine Approach to MCI and Dementia
$1,921,081Kathleen Anne Welsh-Bohmer · Duke University · P30 · FY2010 · AG
Mitochondrial Dysfunction in Aging and Disease
$1,920,859Julie Kay Andersen · Buck Institute For Research On Aging · P01 · FY2010 · AG
Transdisciplinary Research Accelerating Neuropathology Studies and Facilitating Open Research Methods in TBI (TRANSFORM-TBI)
$1,919,827Douglas Hamilton Smith · University Of Pennsylvania · U01 · FY2025 · NS
UCLA Alzeheimer's Disease Research Center
$1,918,951David B Teplow · University Of California Los Angeles · P50 · FY2011 · AG
Building blood based DNA methylation signatures for AD that are reflective of CNS changes
$1,918,750Lily Wang · University Of Miami School Of Medicine · RF1 · FY2019 · AG
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
$1,918,612Japhet Perez · Scripps Institution Of Oceanography · N01 · FY2023 · MH
Defining the Role of DNA Rereplication of Chromosome 21 in the Development and Pathophysiology of Down Syndrome
$1,918,500Joshua Cranston Black · University Of Colorado Denver · R01 · FY2021 · AI
Mayo Alzheimer's Disease Research Center
$1,918,410Ronald C Petersen · Mayo Clinic Rochester · P50 · FY2011 · AG
Mayo Clinic Metabolomics Resource Core
$1,918,202K. Sreekumaran Nair · Mayo Clinic Rochester · U24 · FY2013 · DK
General Anesthesia and Alzheimer's Disease Neuropathogenesis
$1,918,055Zhongcong Xie · Massachusetts General Hospital · RF1 · FY2020 · AG
First in Human Study of a Tau Self-Association Small Molecule Inhibitor in Healthy Volunteers
$1,917,889William A. Erhardt · Oligomerix, Inc · R01 · FY2022 · AG
Interdisciplinary Approach to Alzheimer Drug Discovery
$1,917,793Samuel E Gandy · Thomas Jefferson University · P01 · FY2006 · AG